Healthcare
Thursday, September 15, 2016
BRIEF-Amgen presents positive data at EHMTIC 2016, Erenumab reduces migraine
* Amgen presents positive data at EHMTIC 2016 demonstrating
erenumab significantly reduces monthly migraine days in patients
with chronic migraine
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment